Literature DB >> 21837651

Magnetic resonance imaging-guided microdialysis cannula implantation in a spontaneous high-grade glioma murine model.

Mohamed A Elmeliegy1, Angel M Carcaboso, Lionel M L Chow, Ziwei M Zhang, Christopher Calabrese, Stacy L Throm, Fan Wang, Suzanne J Baker, Clinton F Stewart.   

Abstract

Cerebral microdialysis is used to study anticancer drug penetration in the central nervous system (CNS) and brain tumors in animal models. Genetically engineered murine models (GEMMs) have been recently used to study many aspects of CNS tumors since they represent a more relevant model than orthotopic brain tumor xenograft models. However, it is challenging to implant microdialysis cannula in these animals because T2-weighted magnetic resonance imaging (MRI) does not show the reference point (bregma) traditionally used to obtain stereotactic coordinates. Thus, an alternative reference point that can be visualized on MRI images is needed. In this study, a novel reference point, identified as the intersection between the olfactory bulb/frontal lobe border and the midline between cerebral hemispheres on T2-weighted MRI images, was used to calculate anterior-posterior and medial-lateral coordinates of brain tumors in a GEMM. This point overlies a visible crossover between the rostral rhinal vein and the midline suture on the mouse skull, allowing for the conversion of the MRI coordinates into surgical stereotactic coordinates. Postmortem MRI and histological examination confirmed accurate probe placement. This procedure will facilitate the accurate and precise implantation of microdialysis probes for the study of anticancer drug penetration in brain tumors of GEMMs.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Keywords:  MRI; glioma; microdialysis; spontaneous tumors

Mesh:

Substances:

Year:  2011        PMID: 21837651      PMCID: PMC3750095          DOI: 10.1002/jps.22723

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

1.  Three-dimensional cerebral vasculature of the CBA mouse brain: a magnetic resonance imaging and micro computed tomography study.

Authors:  A Dorr; J G Sled; N Kabani
Journal:  Neuroimage       Date:  2007-01-23       Impact factor: 6.556

Review 2.  Intracerebral microdialysis technique and its application on brain pharmacokinetic-pharmacodynamic study.

Authors:  Yue-Fang Pan; Jian Feng; Qiao-Yuan Cheng; Fan-Zhu Li
Journal:  Arch Pharm Res       Date:  2007-12       Impact factor: 4.946

Review 3.  Microdialysis in mice for drug delivery research.

Authors:  G Boschi; J Scherrmann
Journal:  Adv Drug Deliv Rev       Date:  2000-12-15       Impact factor: 15.470

4.  Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models.

Authors:  Jianguo Ma; Shaolan Li; Karin Reed; Ping Guo; James M Gallo
Journal:  J Pharmacol Exp Ther       Date:  2003-03-06       Impact factor: 4.030

5.  Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.

Authors:  J Ma; S Pulfer; S Li; J Chu; K Reed; J M Gallo
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

6.  Rapid and precise method to locate microdialysis probe implantation in the rodent brain.

Authors:  L Bert; D Favale; G Jego; P Greve; J-P Guilloux; B P Guiard; A M Gardier; M F Suaud-Chagny; P Lestage
Journal:  J Neurosci Methods       Date:  2004-12-30       Impact factor: 2.390

7.  Genetically engineered models have advantages over xenografts for preclinical studies.

Authors:  Oren J Becher; Eric C Holland
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

8.  Microbore HPLC method with online microdialysis for measurement of topotecan lactone and carboxylate in murine CSF.

Authors:  Markos Leggas; Yanli Zhuang; Jonathan Welden; Zack Self; Christopher M Waters; Clinton F Stewart
Journal:  J Pharm Sci       Date:  2004-09       Impact factor: 3.534

9.  Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study.

Authors:  Jaishri O Blakeley; Jeffrey Olson; Stuart A Grossman; Xiaoying He; Jon Weingart; Jeffrey G Supko
Journal:  J Neurooncol       Date:  2008-09-12       Impact factor: 4.130

10.  AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives.

Authors:  Chandra S Chaurasia; Markus Müller; Edward D Bashaw; Eva Benfeldt; Jan Bolinder; Ross Bullock; Peter M Bungay; Elizabeth C M DeLange; Hartmut Derendorf; William F Elmquist; Margareta Hammarlund-Udenaes; Christian Joukhadar; Dean L Kellogg; Craig E Lunte; Carl Henrik Nordstrom; Hans Rollema; Ronald J Sawchuk; Belinda W Y Cheung; Vinod P Shah; Lars Stahle; Urban Ungerstedt; Devin F Welty; Helen Yeo
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

View more
  3 in total

Review 1.  Gene therapy for brain tumors: basic developments and clinical implementation.

Authors:  Hikmat Assi; Marianela Candolfi; Gregory Baker; Yohei Mineharu; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

2.  Antiangiogenic therapy for glioma.

Authors:  Valentina Cea; Carlo Sala; Chiara Verpelli
Journal:  J Signal Transduct       Date:  2012-07-08

3.  Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry.

Authors:  Chen Yuan; Jia-Ye Wang; Hai-Jiao Zhao; Yan Li; Di Li; Hong Ling; Min Zhuang
Journal:  Retrovirology       Date:  2019-12-03       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.